Chicago, IL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)LYNN SAGE BREAST CANCER FOUNDATION, founded in 1985, is a community nonprofit in the Housing & Shelter sector that reported $2.7M in total revenue in fiscal year 2025. Revenue fell 29% from the prior year — a significant decline worth monitoring. Net assets of $8.9M represent 39 months of operating reserves.
The Lynn Sage Breast Cancer Foundation's mission is to eradicate breast cancer by investing in early career doctors and innovative research. Investments are directed locally within the Chicago area, but drive impact globally.
The Lynn Sage Breast Cancer Foundation invests in medical research to help prevent and treat breast cancer, provide critically-needed medical training through grants to fellows, and promote...
The Lynn Sage Breast Cancer Foundation invests in medical research to help prevent and treat breast cancer, provide critically-needed medical training through grants to fellows, and promote collaboration across disciplines through the Lynn Sage Breast Center Symposium. The Chicago Breast Cancer Research Consortium is designed to make clinical trials more accessible for Chicago-area breast cancer patients at University of Chicago Medicine, Robert H Lurie Comprehensive Cancer Center and RUSH MD Anderson Cancer Center.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $2,726,747 | $3,864,106 | -0.3% |
| Expenses | $2,812,267 | $2,157,942 | +0.3% |
| Net Income | $-85,520 | $1,706,164 | -1.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Kirstin Chernawsky | Executive Director | 40 |
Key Emp
Highest
|
$256,250 | $0 | $256,250 |
| Emerson Wells | Director of Programs and Grants | 40 |
Highest
|
$145,480 | $0 | $145,480 |
| Dr Seema Venkatachalam Malkani | Board Chair | 2 |
Officer
Director
|
$0 | $0 | $0 |
| Anna O'Connor | Vice Chair | 2 |
Officer
Director
|
$0 | $0 | $0 |
| Laura Sage | Treasurer | 2 |
Officer
Director
|
$0 | $0 | $0 |
| Dr Kate Nash | Secretary | 2 |
Officer
Director
|
$0 | $0 | $0 |
| Halee Sage | Director | 2 |
Director
|
$0 | $0 | $0 |
| Kristin Wolf | Director | 2 |
Director
|
$0 | $0 | $0 |
| John Barsella | Director | 2 |
Director
|
$0 | $0 | $0 |
| Janika Brenner | Director | 2 |
Director
|
$0 | $0 | $0 |
| Amanda Fayne | Director | 2 |
Director
|
$0 | $0 | $0 |
| Megan Goldish | Director | 2 |
Director
|
$0 | $0 | $0 |
| Dr Dayna Goldstein | Director | 2 |
Director
|
$0 | $0 | $0 |
| Chloe Ifergan | Director | 2 |
Director
|
$0 | $0 | $0 |
| Kathy Josephson | Director | 2 |
Director
|
$0 | $0 | $0 |
| Brian Kirk | Director | 2 |
Director
|
$0 | $0 | $0 |
| Kristin Klein | Director | 2 |
Director
|
$0 | $0 | $0 |
| Molly Kovler | Director | 2 |
Director
|
$0 | $0 | $0 |
| Eva Laser | Director | 2 |
Director
|
$0 | $0 | $0 |
| Sylvia Michas | Director | 2 |
Director
|
$0 | $0 | $0 |
| Alison Mitchell | Director | 2 |
Director
|
$0 | $0 | $0 |
| Paul O'Keefe | Director | 2 |
Director
|
$0 | $0 | $0 |
| Jenny Stevens | Director | 2 |
Director
|
$0 | $0 | $0 |
| Sarah Rudich | Director | 2 |
Director
|
$0 | $0 | $0 |
| Dana Sanders | Director | 2 |
Director
|
$0 | $0 | $0 |
| Audrey Selin | Director | 2 |
Director
|
$0 | $0 | $0 |
| Tucker Woolfolk | Director | 2 |
Director
|
$0 | $0 | $0 |
| Sheri Whitko | Director | 2 |
Director
|
$0 | $0 | $0 |
| Jill Alberts Mills | Director | 2 |
Director
|
$0 | $0 | $0 |
| Dr Sonya Bhole | Director | 2 |
Director
|
$0 | $0 | $0 |
| Dr Alana Biggers Walker | Director | 2 |
Director
|
$0 | $0 | $0 |
| John DeCaro | Director | 2 |
Director
|
$0 | $0 | $0 |
| Suzanne Le Mignot | Director | 2 |
Director
|
$0 | $0 | $0 |
| Suchita Shah | Director | 2 |
Director
|
$0 | $0 | $0 |
| Meredith Soren Freese | Director | 2 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $2,726,747 | $2,812,267 | $8,923,856 | $-85,520 |
| 2024 | $3,864,106 | $2,157,942 | $8,343,105 | $1,706,164 |
| 2023 | $2,222,700 | $1,653,684 | $6,459,675 | $569,016 |
| 2022 | $1,163,257 | $1,567,056 | $5,519,974 | $-403,799 |
| 2021 | $2,129,193 | $1,032,739 | $6,202,137 | $1,096,454 |
| 2020 | $930,159 | $638,070 | $4,090,701 | $292,089 |
| 2019 | $1,322,384 | $871,607 | $3,672,767 | $450,777 |
| 2018 | $1,361,162 | $687,351 | $2,953,136 | $673,811 |
Compare LYNN SAGE BREAST CANCER FOUNDATION with other nonprofits in Illinois and across the country.